Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep447 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The effect of lockdown during covid 19 pandemic on HbA1c control among diabetes patients in georgia ajara

Jashi Liana , Dundua Ketevan , Kvanchakhadze Rusudan , Peshkova Tamar

Background: The COVID-19 pandemic changed to the daily life of individuals. These included lockdown and social distancing During COVID-19 pandemic. Healthcare providers from different institutions had to adapt to the way of supporting and managing patients with different chronic conditions including diabetes. The implementation of lockdown affected diabetes care. COVID-19 pandemic enabled healthcare professionals to apply innovation including social networks/telemedicine/telep...

ea0073aep170 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Impact of social isolation and quarantine on the course of diabetes mellitus and its complications during Covid 19 pandemic in Adjara Region Country of Georgia

Jashi Liana , Dundua Ketevan , Kvanchakhadze Rusudan , Nizharadze Nino

BackgroundSARS-CoV-2 infection produces greater morbidity and mortality in people with cardiovascular disease, diabetes, and obesity. Quarantine and social distancing are necessary measures to prevent the virus from spreading but also lead to elevated levels of loneliness and social isolation. The aim of the study was to research impact of Social isolation and quarantine on compensation of diabetes and on progression of its complications.<p class="ab...

ea0084ps1-01-09 | COVID & Thyroid Disease | ETA2022

Subacute thyroiditis after SARS-CoV-2 vaccine

Peshkova Tamar , Khurana Rajneesh , Kamashidze Koba , Jashi Liana

Introduction: Subacute thyroiditis (SAT) is an inflammatory disorder of thyroid associated with viral infections. Rarely, cases of SAT have also been described post-vaccination, but there are not many reports related to exposure to the COVID-19 vaccine. Here, we present a case of subacute thyroiditis after receiving the first dose of a SARS-CoV-2 vaccination inactivated COVID-19 vaccine (Sinovac-CoronaVac, developed by Sinovac/China National Pharmaceutical Group).<p class=...